StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$414.12−3.68 (-0.88%)

Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%

West Pharmaceutical Services price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

West Pharmaceutical Services's price to book ratio was 9.7× on Nov 11, 2026, against 6.5× a year earlier. Over the last 5 years it ranged from 5.4× to 15.8×, with a median of 8.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.7×+3.2
2025Dec 31, 20256.5×−2.1
2024Dec 31, 20248.6×−0.5
2023Dec 29, 20239.1×+2.0
2022Dec 30, 20227.0×−8.7
2021Dec 31, 202115.8×+3.6
2020Dec 31, 202012.2×+4.7
2019Dec 31, 20197.5×+2.4
2018Apr 30, 20185.1×–

More West Pharmaceutical Services figures

See a number that looks wrong?